Intensive immunosuppression in the treatment of multiple sclerosis.
D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D002478:Cells, Cultured; D004322:Drainage; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006386:Hemagglutination Tests; D006736:Horses / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D005779:Immunodiffusion; D007074:Immunoglobulin G; D007165:Immunosuppression Therapy; D007275:Injections, Intravenous; D008231:Lymphopenia / Q000276:immunology; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012882:Skin Tests; D013897:Thoracic Duct; D005719:gamma-Globulins / Q000032:analysis
D000961:Antilymphocyte Serum; D007074:Immunoglobulin G; D005719:gamma-Globulins; D011239:Prednisolone; D001379:Azathioprine